163 related articles for article (PubMed ID: 14989459)
1. Proteinuria and its consequences in renal disease.
Schieppati A; Remuzzi G
Acta Paediatr Suppl; 2003 Dec; 92(443):9-13; discussion 5. PubMed ID: 14989459
[TBL] [Abstract][Full Text] [Related]
2. Renal pathological changes in Fabry disease.
Sessa A; Meroni M; Battini G; Maglio A; Brambilla PL; Bertella M; Nebuloni M; Pallotti F; Giordano F; Bertagnolio B; Tosoni A
J Inherit Metab Dis; 2001; 24 Suppl 2():66-70; discussion 65. PubMed ID: 11758681
[TBL] [Abstract][Full Text] [Related]
3. Renal manifestations in Fabry disease and therapeutic options.
Torra R
Kidney Int Suppl; 2008 Dec; (111):S29-32. PubMed ID: 19039306
[TBL] [Abstract][Full Text] [Related]
4. Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.
Tahir H; Jackson LL; Warnock DG
J Am Soc Nephrol; 2007 Sep; 18(9):2609-17. PubMed ID: 17656478
[TBL] [Abstract][Full Text] [Related]
5. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
[TBL] [Abstract][Full Text] [Related]
6. The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises.
Schieppati A; Remuzzi G
Kidney Int; 2003 Dec; 64(6):1947-55. PubMed ID: 14633117
[No Abstract] [Full Text] [Related]
7. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
[TBL] [Abstract][Full Text] [Related]
8. [Management of chronic kidney disease--preventing the progression of renal disease].
Kuroki A; Akizawa T
Nihon Rinsho; 2008 Sep; 66(9):1735-40. PubMed ID: 18788403
[TBL] [Abstract][Full Text] [Related]
9. Evolution of renal pathology in Fabry disease.
Sessa A; Meroni M; Battini G; Righetti M; Nebuloni M; Tosoni A; Vago GL;
Acta Paediatr Suppl; 2003 Dec; 92(443):6-8; discussion 5. PubMed ID: 14989458
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
Garini G; Allegri L; Arisi L
Ann Ital Med Int; 1989; 4(3):184-94. PubMed ID: 2702030
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic measures in proteinuric nephropathy.
Praga M
Kidney Int Suppl; 2005 Dec; (99):S137-41. PubMed ID: 16336567
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy and Fabry nephropathy.
Warnock DG; Daina E; Remuzzi G; West M
Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors in chronic renal failure.
Opsahl JA; Abraham PA; Keane WF
Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease. A case report.
Kotnik J; Kotnik F; Desnick RJ
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
16. Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.
Doleželová Š; Jíchová Š; Husková Z; Vojtíšková A; Kujal P; Hošková L; Kautzner J; Sadowski J; Červenka L; Kopkan L
Clin Exp Hypertens; 2016; 38(7):644-651. PubMed ID: 27669111
[TBL] [Abstract][Full Text] [Related]
17. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
18. [Renal lesions in patients with Fabry's disease].
Gubler MC
Rev Med Interne; 2010 Dec; 31 Suppl 2():S220-5. PubMed ID: 21211668
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria: detection and role in native renal disease progression.
Gorriz JL; Martinez-Castelao A
Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
[TBL] [Abstract][Full Text] [Related]
20. Progression of chronic renal disease.
Klahr S
Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]